V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
2024 CHICAGO, IL Jul. 28 -Aug.1
ISSN 1068-1760
Vol.41 No.4 • 7/2024
DAILY CLINICAL LAB NEWS
®
I
N
T
AI Accurately Predicts Tumor-Killing Cells ellular immunotherapy involves extracting immune cells from a patient’s tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body. T cells, a primary type of
C
E
R
N
A
T
I
O
Clinical Decision Software a Game-Changer in the Antimicrobial Resistance Battle ntimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces the efficacy of treatments for various
A
infectious diseases, jeopardizing significant medical advancements and substantially inflating healthcare costs. The World Health Organization (WHO) stresses the importance of preventing infections, ensuring universal access to quality diagnostic and treatment
Cont’d on page 6
Cont’d on page 4
Organ Transplant Rejection Test Could Replace Surgical Biopsies
I
S
I
T
LINKXPRESS COM R E A D E R
S E R V I C E
®
Cont’d on page 8
Test Cuts UTI Detection to 45 Minutes ntimicrobial Resistance (AMR), is a silent but growing pandemic where bacteria have become resistant to lifesaving antibiotics due to decades of overuse and misuse. In 2019, AMR was responsible for nearly 1.3 million deaths worldwide and is projected to cause 10 million deaths annually by 2050. Urinary Tract Infections
A
Access Interactive Digital Magazine Instant Online Product Information:
Cont’d on page 10
New Guidelines for Respiratory Viral Infection Testing
Identify LinkXpress ® codes of 1 interest as you read magazine
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
uberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed with TB, and it’s estimated that as many as one-quarter of the global population may be infected with Mycobacterium tuberculosis (MTB). Effective TB control requires healthcare pro-
T
lzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible to slow down its progression. The results of a groundbreaking study, recently published in the journal Nature Communications, have offered new hope for not
Image: Human cells secreting exosomes, illustration (Adobe Stock)
Renew/Start your Free Subscription
Mark code(s) of interest on 3 LinkXpress ® inquiry matrix
New Era in Automated Tuberculosis Testing
A
P O R T A L
on LinkXpress.com 2 toClick reach reader service portal
L
Pre-Dementia Alzheimer’s Test
B
V
A
Cont’d on page 5
y using T cell exosomes as a biomarker that is significantly altered during the organ rejection process, researchers have developed a breakthrough blood test that can accurately monitor acute cellular rejection (ACR) after an organ transplant. See article on page 11
N
espiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management. In light of the COVID-19 pandemic,
R
there have been significant advancements in laboratory medicine, enhancing the testing capabilities for respiratory viruses. These advancements include the use of diverse sample types and the introduction of various new testing methods. However, these Cont’d on page 14
INSIDE LabMedica EXPO . 6-24 Clinical News . . . . 4-24 IFCC News . . . . 25-28 Industry News .. . . . 29 Events Calendar . . 30 PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<